AGREEMENT AND PLAN OF MERGER among EQUILLIUM, INC., METACRINE, INC., EQUILLIUM ACQUISITION SUB, INC. and TRIUMPH MERGER SUB, INC. Dated as of September 6, 2022Merger Agreement • September 6th, 2022 • Metacrine, Inc. • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER (hereinafter referred to as this “Agreement”), dated as of September 6, 2022, among METACRINE, INC., a Delaware corporation (the “Company”), EQUILLIUM, INC., a Delaware corporation (“Parent”), EQUILLIUM ACQUISITION SUB, INC., a Delaware corporation and a direct wholly owned Subsidiary of Parent, (“Acquisition Sub”), and TRIUMPH MERGER SUB, INC., a Delaware corporation and a direct wholly owned Subsidiary of Acquisition Sub (“Merger Sub”). Parent, Acquisition Sub, Merger Sub and the Company are each sometimes referred to herein as a “Party” and collectively as the “Parties”.
